PCRX vs LLY: Which Stock is Better?
Side-by-side comparison of Pacira BioSciences, Inc. and Eli Lilly and Company in 2026
PCRX
Pacira BioSciences, Inc.
—
LLY
Eli Lilly and Company
$1235.56
Key Metrics Comparison
| Metric | PCRX | LLY | Winner |
|---|---|---|---|
| Market Cap | $890.84M | $991.62B | LLY |
| P/E Ratio | 174.15 | 39.47 | LLY |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze PCRX
Full quant analysis
Analyze LLY
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PCRX or LLY a better investment?
Comparing PCRX and LLY: Pacira BioSciences, Inc. has a market cap of $890.84M while Eli Lilly and Company has $991.62B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PCRX and LLY?
PCRX (Pacira BioSciences, Inc.) and LLY (Eli Lilly and Company) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PCRX or LLY?
Based on P/E ratios, LLY trades at a lower multiple (39.5x vs 174.2x).
Which is growing faster: PCRX or LLY?
Both PCRX and LLY show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: PCRX or LLY?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: PCRX or LLY?
Eli Lilly and Company (LLY) is larger with a market cap of $991.62B compared to $890.84M for PCRX.
Should I buy PCRX or LLY in 2026?
Both PCRX and LLY have investment merit. PCRX trades at $N/A while LLY trades at $1235.56. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PCRX and LLY stock?
Key differences: Market Cap ($890.84M vs $991.62B), P/E Ratio (174.2x vs 39.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy PCRX or LLY in 2026?
The choice between PCRX and LLY depends on your investment goals. LLY shows higher revenue growth (0.0%). LLY has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between PCRX and LLY?
PCRX (Pacira BioSciences, Inc.) has a market cap of $890.84M, while LLY (Eli Lilly and Company) has a market cap of $991.62B. LLY is the larger company by market value.